WO1999063928A3 - Pharmaceutical product for hemophilia and asthmatic bronchitis treatment - Google Patents

Pharmaceutical product for hemophilia and asthmatic bronchitis treatment Download PDF

Info

Publication number
WO1999063928A3
WO1999063928A3 PCT/BR1999/000042 BR9900042W WO9963928A3 WO 1999063928 A3 WO1999063928 A3 WO 1999063928A3 BR 9900042 W BR9900042 W BR 9900042W WO 9963928 A3 WO9963928 A3 WO 9963928A3
Authority
WO
WIPO (PCT)
Prior art keywords
hemophilia
pharmaceutical product
asthmatic bronchitis
molecular chain
bronchitis treatment
Prior art date
Application number
PCT/BR1999/000042
Other languages
French (fr)
Other versions
WO1999063928A2 (en
Inventor
Akira Yoshitome
Eiji Sato
Naul Ozi
Original Assignee
Akira Yoshitome
Eiji Sato
Naul Ozi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akira Yoshitome, Eiji Sato, Naul Ozi filed Critical Akira Yoshitome
Priority to AU45943/99A priority Critical patent/AU4594399A/en
Publication of WO1999063928A2 publication Critical patent/WO1999063928A2/en
Publication of WO1999063928A3 publication Critical patent/WO1999063928A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a pharmaceutical product for hemophilia and asthmatic bronchitis treatment comprising a natural polymer composed by a molecular chain comprising of 1 to 5000 monomers, being said polymer classified according to the set below, with its related acting ratios: a) β-1,4-poly-N-acetyl-D-glucosamine, with a fractionated molecular chain ratio of 0 % to 100 %; and b) β-1,4-poly-D-glucosamine, with a fractionated molecular chain ratio of 0 % to 100 %.
PCT/BR1999/000042 1998-06-09 1999-06-09 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment WO1999063928A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU45943/99A AU4594399A (en) 1998-06-09 1999-06-09 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI9806540-8 1998-06-09
BR9806540-8A BR9806540C1 (en) 1998-06-09 1998-06-09 Pharmaceutical product for the treatment of hemophilia and asthmatic bronchitis

Publications (2)

Publication Number Publication Date
WO1999063928A2 WO1999063928A2 (en) 1999-12-16
WO1999063928A3 true WO1999063928A3 (en) 2000-02-03

Family

ID=4071490

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/BR1999/000042 WO1999063928A2 (en) 1998-06-09 1999-06-09 Pharmaceutical product for hemophilia and asthmatic bronchitis treatment

Country Status (3)

Country Link
AU (1) AU4594399A (en)
BR (1) BR9806540C1 (en)
WO (1) WO1999063928A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0640346A1 (en) * 1987-12-21 1995-03-01 BM Research A/S Uses of sulphated sugars against inflammation
WO1996041818A1 (en) * 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
WO1998004133A1 (en) * 1996-07-29 1998-02-05 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0640346A1 (en) * 1987-12-21 1995-03-01 BM Research A/S Uses of sulphated sugars against inflammation
WO1996041818A1 (en) * 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
WO1998004133A1 (en) * 1996-07-29 1998-02-05 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin

Also Published As

Publication number Publication date
AU4594399A (en) 1999-12-30
WO1999063928A2 (en) 1999-12-16
BR9806540A (en) 2001-03-06
BR9806540C1 (en) 2001-05-08

Similar Documents

Publication Publication Date Title
EP2261266A3 (en) Process for the polymerization of a monomer with a catalyst composition containing an organometal compound, an organoaluminum compound and a treated solid oxide compound
BR0214136A (en) Graft polymers, process for preparation and use thereof
TW334443B (en) Linear block copolymers, process for their preparation and adhesive compositions
AU5857499A (en) Conjugated polymers containing 2,7 fluorenyl units with improved properties
AU698910B2 (en) Ethylene copolymers having narrow composition distribution, their production and use
AU5061899A (en) Anti-ulcer composition
WO2000012508A3 (en) Pyrrolbenzodiazepines
EP0906932A3 (en) Film and stretch packaging film
MXPA04004049A (en) Graft polymer with sidechains comprising nitrogen heterocycles.
ATE192429T1 (en) ETHYLENE UNSATURATED 1,3-DIKETOAMIDE FUNCTIONAL COMPOUNDS, POLYMERS THEREOF AND LATEX COMPOSITIONS CONTAINING SAME
CA2279300A1 (en) Polyesteramides from cyclic monomers and surgical articles made therefrom
EP0355497A3 (en) Polyorganosiloxane compounds
NZ504117A (en) Polymeric compositions, and the preparation and use thereof
WO2002009789A3 (en) Medical technical product, method for producing the same and providing the same for surgery
EP0845484A3 (en) Copolymer, hydrogenated product thereof, and process for producing the same
CA2197544A1 (en) Fungicidal composition comprising metalaxyl and fludioxonil
CA2180533A1 (en) Process for producing aromatic or heteroaromatic sulfur compounds
EP1002808A4 (en) Copolymer, process for producing the same, and molded article comprising the same
CA2292137A1 (en) High transparency polymeric composition
BG101235A (en) Method for the preparation of granules from acryl-based polymers
WO1999063928A3 (en) Pharmaceutical product for hemophilia and asthmatic bronchitis treatment
EP0223858A4 (en) Polymer composition and use thereof.
AU2001289689A1 (en) Partially branched polymers
CA2284030A1 (en) Polymer composition, the production and further processing thereof into receptacles
CA2195283A1 (en) Process for manufacturing iron dextran using ultrafiltration

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA NO US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA NO US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA